FutureDose.tech

Why Every Tech Company in Pharmacy needs a Pharmacist - PPN Episode 905

Timothy Aungst, PharmD, the Digital Apothecary shares his views on "Why every tech company needs a pharmacist on staff." 
Learn more about Tim here: 
https://www.thedigitalapothecary.com/biography 
This episode was sponsored by the California Pharmacist Association WPE 2020
https://cpha.com/cphaevents/wpe/ 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Why do Digital Health Companies focused on Medication Adherence struggle? - PPN Episode 901

Timothy Aungst, PharmD host of FutureDose.tech talks about the recent focus on the issues plaguing digital health companies focused on medication adherence, which seem to come from the fact that adherence alone is not the problem, but optimization of therapy from data collected.
Tim presents some of the trends I've seen and thoughts on what can be done to change these problems.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Medication Nonadherence does NOT cost $300 Billion but Medication Non-Optimization Costs More - PPN Episode 887

MEDICATION ADHERENCE IS NOT A $300 BILLION PROBLEM
(Change my Mind)
Medication adherence holds a soft spot for me, likely due to my professional background as a pharmacist. I cannot tell you how often medication adherence comes up daily when addressing patient care. Even in the home healthcare setting, we have multiple nurses that are dedicated to visiting and administering medications to patients (usually those with a psych history or SUD or related comorbidities that impede medication use). I love the idea of technology aiding in medication adherence, and if you follow my work, you know that I have been reviewing apps and devices for almost a decade now. Nonetheless, I cannot but help notice a trend that is, I believe, really cutting out pharmacists from the medication "adherence" disruption space.
Heres the problem: Medication adherence is not a $300 Billion problem, and that may shock you. After all, almost every company website I visit discusses how they will transform healthcare with their solution/product by focusing on their intervention will reduce the cost of adherence in the US. And I cannot help but think this narrative is killing the pharmacy profession because it opens up a very different tale to the actual problem that is favorable to only a few people.
TIMOTHY AUNGST NOVEMBER 1, 2019
LINK: 
https://www.thedigitalapothecary.com/pharmacy-innovation-news/2019/11/1/medication-adherence-is-not-a-300-billion-problem 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

the Digital Apothecary Update - PPN Episode 795

Digital Apothecary: 
https://www.thedigitalapothecary.com/musings 
It's increasingly becoming a digital world, and businesses are looking to turn healthcare into the next field to reap the benefits of rampant technological growth. After all, its a multi-billion dollar market, we have an aging population, and new therapies are coming to the field all the time. For me, keeping up with all of these developments has increasingly been a fund endeavor, but over the years I have found many people asking me for input on new technologies and their impact on the pharmacy landscape and patient care opportunities. For that reason, I created The Digital Apothecary as a place for people to read about novel tools, devices, and developments that I think may make a difference. 
Why the focus on Digital Health?
It's an amazing time for patients to be able to use wearable devices to capture data in realtime and share it with their health team. I love to watch what is being developed and imagine how pharmacy can use this to monitor therapeutic outcomes and improve care.
Timothy Aungst, PharmD is an Associate Professor of Pharmacy Practice at MCPHS University, Worcester, MA. He graduated from Wilkes University Nesbitt School of Pharmacy, Wilkes-Barre, PA, in 2011. Afterwards, he pursued a PGY-1 Pharmacy Practice Residency at St. Luke's University Hospital, Bethlehem, PA, with an emphasis on Internal Medicine, Cardiology, and Geriatric Care. He then completed a fellowship program focused on geriatric care, Medicare/Medicaid and drug management, and academia.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2019 The Year of Digital Health - FutureDose.tech - PPN Episode 759

Articles of Interest Links:
AdhereTech - https://www.mobihealthnews.com/content/adheretech-raises-growth-equity-round-scale-improve-smart-pill-bottle-based-adherence
Pear Therapeutics reSET-O FDA Clearance - https://www.mobihealthnews.com/content/pears-digital-therapeutic-reset-o-fda-cleared-treat-opioid-use-disorder
Beddit Apple Launch - https://www.mobihealthnews.com/content/fcc-document-suggests-apple-may-launch-new-beddit-device
POPS! Diabetes clearance - https://www.mobihealthnews.com/content/pops-diabetes-care-scores-510k-connected-glucose-monitoring-system
Remote Patient Monitoring - https://www.mobihealthnews.com/content/big-changes-are-coming-medicare-reimbursement-connected-health
Pillsy subscription service - https://www.mobihealthnews.com/content/smart-pill-bottle-cap-company-launches-supplement-subscription-service
Alto raises $50 Million - https://www.mobihealthnews.com/content/altos-digital-pharmacy-prescription-delivery-service-closes-50m-round
FDA Opioid Challenge Winners - https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHInnovation/ucm609082.htm
FDA Digital Health Action Plan - https://www.fda.gov/downloads/MedicalDevices/DigitalHealth/UCM568735.pdf
Tabula Rasa acquires DoseMe - https://www.mobihealthnews.com/content/tabula-rasa-healthcare-acquires-fellow-medication-safety-platform-doseme
ResMed acquires Propeller for $225 Million - https://www.mobihealthnews.com/content/resmed-acquires-digital-respiratory-health-company-propeller-health
Pharmacy Gig Economy - https://www.mobihealthnews.com/content/aspen-rxhealth-gets-9m-create-gig-economy-pharmacists
Novo Nordisk Smart Insulin Pens - https://diatribe.org/novopen-6-and-novopen-echo-plus-connected-insulin-pens-launch-early-2019?utm_source=facebook&utm_medium=organic&fbclid=IwAR1QO9e-lfY0G173XNhitGhUs1AT0xv-XyYeyuVtmDh9KXC18UgUHlxUH9A
Research Articles of Interest:
Interventions to Improve Medication Adherence: A Review - https://www.ncbi.nlm.nih.gov/pubmed/30561486
Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort - https://www.ncbi.nlm.nih.gov/pubmed/30552914
What is an appropriate level of evidence for a digital health intervention? - https://www.ncbi.nlm.nih.gov/pubmed/30545779
Continuous Temperature-Monitoring Socks for Home Use in Patients With Diabetes: Observational Study - https://www.ncbi.nlm.nih.gov/pubmed/30559091
Smartphone apps for insomnia: examining existing apps' usability and adherence to evidence-based principles for insomnia management - https://www.ncbi.nlm.nih.gov/pubmed/30590862
Use of a Digital Medication Management System for Effective Assessment and Enhancement of Patient Adherence to Therapy (ReX): Feasibility Study - https://humanfactors.jmir.org/2018/4/e10128/
Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study - https://www.ncbi.nlm.nih.gov/pubmed/30392584
A Digital Language Divide? The Relationship between Internet Medication Refills and Medication Adherence among Limited English Proficient (LEP) Patients - https://www.ncbi.nlm.nih.gov/pubmed/29600351
Community pharmacist perceptions of their role and the use of social media and mobile health applications as tools in public health - https://www.ncbi.nlm.nih.gov/pubmed/29501431
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Digital Therapeutics - FutureDose.Tech - PPN Episode 740

FutureDose host Dr. Timothy Aungst talks about Digital therapeutics as the new area in the Digital Health field creating evidence-based software for clinical treatment of diseases.
The Digital Health Alliance has released an industry report on the current state of DTx https://www.dtxalliance.org/wp-content/uploads/2018/09/DTA-Report_DTx-Industry-Foundations.pdf
Feel free to read my blog post on the topic and an introduction to digital therapeutics with more details that this podcast is based upon https://www.thedigitalapothecary.com/pharmacy-innovation-news/2018/11/28/an-introduction-to-digital-therapeutics-and-relevance-to-clinical-practice
Timothy Dy Aungst, PharmD Associate Professor | Freelance Writer & Consultant @TDAungst
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

AMA Digital Health Playbook FutureDose.Tech - PPN Episode 738

Timothy D. Aungst PharmD, delivers another FutureDose.Tech episode about the AMA Digital Health Playbook. 
The American Medical Association (AMA) has not been silent compared to other medical organizations around its views on digital health. They have had an open discourse in the past year and partnered with many outside organizations to quantify and assess the implications of the digital health space in medical practice. If you were not aware (or a part of), the AMA has had several open networks inciting discussions and joint thoughts on digital health and established a digital health leadership program.
As part of this program, there has been an interest in delivering care using digital health, with a focus on Validation & Evidence, Payment, Liability & Risk, and Adoption & Scale. While these may be ambivalent terms, the AMA has put its word into more action with their recently released "Digital Health Implementation Playbook" (you can download it here but will need to submit some user data). I have read this document a few times and reflected on its implications to practice, which I will detail henceforth.
The Playbook is 95 pages long, and 66 pages actually dedicated towards essential content with the remainder being ancillary supporting documents and tools to integrate into clinical use. Overall, a lot of the material is image and graph-heavy, with not a lot of actual text, and with many quotes and such thrown in. I would say perhaps if they just stuck with actual text like a whitepaper this thing may only be

Mobile Insulin Management and Tech of the Future - FutureDose.Tech - PPN Episode 728

Timothy Dy Aungst, PharmD, is an associate professor of pharmacy practice at MCPHS University. He graduated from Wilkes University Nesbitt School of Pharmacy and completed a PGY-1 Pharmacy Practice Residency at St. Luke's University Hospital, and then a Clinical Geriatric Fellowship at MCPHS University. He is passionate about the rise of technology in health care and its application to pharmacy. He has published primarily on the role of mobile technology and mHealth, and made multiple national and international presentations on those topics. He blogs at TheDigitalApothecary.com, is a Co-Host of FutureDose.Tech a podcast part of the Pharmacy Podcast Network, and you can find him on Twitter @TDAungst.
Forbes Technology Council Meghann Chilcott Senior Vice President of OrderInsite, delivering executive leadership in innovative pharmacy technology solutions. An executive leader in Pharmacy Technology, I help companies achieve revenue goals with a passion for process improvements through the successful execution of deliverables, backed by deep industry expertise and comprehensive management experience. A strategic and analytical professional, I develop business initiatives quickly and with precision. 
Personal Email: meghannc@me.com  Business Email: mchilcott@orderinsite.com 
 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

What’s Your Data Storage Solution? Introducing SNOWFLAKE - PPN Episode 722

WHAT'S THE SNOWFLAKE ARCHITECTURAL DIFFERENCE? 
Meghann Chilcott is the host of FutureDose.Tech and interviews Todd Crosslin, the VP of Healthcare Strategy at Snowflake Computing. 
Snowflake’s unique data warehouse architecture provides complete relational database support for both structured data, such as CSV files and tables, and semi-structured data, including JSON, Avro, Parquet, etc., all within a single, logically integrated solution. Snowflake is a data warehouse-as-a-service, which requires no management and features separate compute, storage, and cloud services that can scale and change independently.
Metadata is also automatic. What’s more, metadata processing within Snowflake does not compete with the compute resources running your queries. This means Snowflake can scale near-linearly as your compute resources scale out. Secure by design and compatible with popular ETL and BI tools, Snowflake enables data warehouse managers to support enterprise-wide data warehouse requirements with virtually unlimited concurrency.
Snowflake is also a powerful query processing back-end platform for developers creating modern data-driven applications.
https://www.snowflake.com/product/why-snowflake/ 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Apple Watch Series 4 and Pharmacy: FutureDose.Tech - PPN Episode 713

Notes from Digital Apothecary on Apple Watch Series 4.
The recent Apple event was pretty tame compared to past years, with three new iPhones and Watch announced. Overall, a lot of this news had been floating around for the past few days before the event, but one item that caught my attention was the integration of an EKG sensor into the Series 4 Apple Watch.
Indeed, the event did highlight a bunch of new health features of the Apple Watch, including a bigger size and such, but two health items caught my attention:
ECG - A 30s ECG is being added after FDA approval to the Apple Watch that can detect arrhythmia’s (more specifically A. Fib). This is perhaps the biggest item being discussed in the Apple/Digital health field at the time, which I’ll go into detail further along.
Fall Risk - If you fall, the Apple Watch will allow you call for medical aid, and if no response is logged after 60 seconds. Now, I love this to a certain point. I think it’s going to be a good feature for those that want to enable it - and could be something recommended for patients at a high fall risk. It is a timely feature, given the recent acquisition of GreatCall by BestBuy lately, so Apple is definitely paying attention to how to leverage its device for services.
Expanded App Design - Some of the images released of how the Apple Watch can display data integrated with mobile apps for health-related purposes were really cool I thought, such as Dexcom CGM and Clue period tracker. Really nice interfaces that I think can help remind users to engage in their use, which often seems forgotten and leads to drop off for most of these health apps.
https://www.thedigitalapothecary.com/pharmacy-innovation-news/2018/9/13/lets-talk-about-the-new-apple-watch-and-what-it-means-for-health 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices